東邦 HD（8129）のセグメントごとの売上高・利益等
セグメント通期
- 【有報】
- セグメント情報等、連結財務諸表
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
|---|---|---|---|---|
| 売上高 | 2013/03 | 800億 | - | 1.06兆 |
| 2014/03 | 856億 +7% | - | 1.1兆 +4.1% | |
| 2015/03 | 921億 +7.5% | - | 1.07兆 -3.1% | |
| 2016/03 | 998億 +8.4% | - | 1.21兆 +13% | |
| 2017/03 | 955億 -4.3% | - | 1.13兆 -6% | |
| 2018/03 | 977億 +2.3% | - | 1.11兆 -1.8% | |
| 2019/03 | 929億 -4.8% | - | 1.13兆 +1.3% | |
| 2020/03 | 959億 +3.2% | - | 1.17兆 +3.4% | |
| 2021/03 | 911億 -5% | 22.5億 | 1.12兆 -4.3% | |
| 2022/03 | 918億 +0.8% | 19億 -15.6% | 1.17兆 +4.7% | |
| 2023/03 | 923億 +0.6% | 21.1億 +10.8% | 1.29兆 +10.7% | |
| 2024/03 | 938億 +1.6% | 24.4億 +16% | 1.38兆 +6.4% | |
| 2025/03 | 955億 +1.9% | 26.2億 +7.1% | 1.42兆 +2.9% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 営業利益 | 2013/03 | 13.1億 | - | 117億 |
| 2014/03 | 10.9億 -16.4% | - | 115億 -2.2% | |
| 2015/03 | 16億 +45.9% | - | 82.7億 -27.8% | |
| 2016/03 | 29.2億 +83.3% | - | 273億 +230.2% | |
| 2017/03 | 12.4億 -57.5% | - | 140億 -48.8% | |
| 2018/03 | 35.6億 +186.5% | - | 172億 +22.6% | |
| 2019/03 | 14.3億 -60% | - | 161億 -6.2% | |
| 2020/03 | 27億 +89.5% | - | 180億 +12% | |
| 2021/03 | 26.9億 -0.4% | 729百万 | 39.7億 -78% | |
| 2022/03 | 29.6億 +10.2% | 884百万 +21.3% | 99.7億 +151.1% | |
| 2023/03 | 24.3億 -18% | 864百万 -2.3% | 140億 +40.4% | |
| 2024/03 | 15.5億 -36.4% | 755百万 -12.6% | 195億 +39% | |
| 2025/03 | 8.52億 -44.9% | 729百万 -3.4% | 190億 -2.2% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 営業利益率 | 2013/03 | 1.6% | - | 1.1% |
| 2014/03 | 1.3% -0.3% | - | 1% -0.1% | |
| 2015/03 | 1.7% +0.4% | - | 0.8% -0.2% | |
| 2016/03 | 2.9% +1.2% | - | 2.3% +1.5% | |
| 2017/03 | 1.3% -1.6% | - | 1.2% -1.1% | |
| 2018/03 | 3.6% +2.3% | - | 1.5% +0.3% | |
| 2019/03 | 1.5% -2.1% | - | 1.4% -0.1% | |
| 2020/03 | 2.8% +1.3% | - | 1.5% +0.1% | |
| 2021/03 | 3% +0.2% | 32.4% | 0.4% -1.1% | |
| 2022/03 | 3.2% +0.2% | 46.6% +14.2% | 0.9% +0.5% | |
| 2023/03 | 2.6% -0.6% | 41% -5.6% | 1.1% +0.2% | |
| 2024/03 | 1.6% -1% | 30.9% -10.1% | 1.4% +0.3% | |
| 2025/03 | 0.9% -0.7% | 27.9% -3% | 1.3% -0.1% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 固定資産増加額 | 2013/03 | 9.75億 | - | 126億 |
| 2014/03 | 18.3億 +88.1% | - | 118億 -6.6% | |
| 2015/03 | 16.8億 -8.4% | - | 28.5億 -75.7% | |
| 2016/03 | 17.5億 +4.2% | - | 49億 +71.7% | |
| 2017/03 | 9.58億 -45.3% | - | 80.3億 +64% | |
| 2018/03 | 5.34億 -44.3% | - | 85.2億 +6.2% | |
| 2019/03 | 7.82億 +46.4% | - | 30.4億 -64.4% | |
| 2020/03 | 20.4億 +161.4% | - | 123億 +303.7% | |
| 2021/03 | 19.1億 -6.4% | 1.32億 | 39.8億 -67.5% | |
| 2022/03 | 4.44億 -76.8% | 1.26億 -4.5% | 37.2億 -6.5% | |
| 2023/03 | 5.84億 +31.5% | 1.35億 +7.1% | 22.9億 -38.5% | |
| 2024/03 | 6.47億 +10.8% | 1.57億 +16.3% | 22.1億 -3.4% | |
| 2025/03 | 8.55億 +32.1% | 17.7億 +999.99% | 35.9億 +62.3% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 従業員数 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | 2,450 | - | 5,170 | |
| 2020/03 | 2,473 +0.9% | - | 5,051 -2.3% | |
| 2021/03 | 2,398 -3% | 90 | 4,934 -2.3% | |
| 2022/03 | 2,468 +2.9% | 98 +8.9% | 4,800 -2.7% | |
| 2023/03 | 2,563 +3.8% | 100 +2% | 4,656 -3% | |
| 2024/03 | 2,546 -0.7% | 101 +1% | 4,530 -2.7% | |
| 2025/03 | 2,648 +4% | 102 +1% | 4,450 -1.8% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 平均臨時雇用人員 | 2013/03 | - | - | - |
| 2014/03 | - | - | - | |
| 2015/03 | - | - | - | |
| 2016/03 | - | - | - | |
| 2017/03 | - | - | - | |
| 2018/03 | - | - | - | |
| 2019/03 | 784 | - | 1,621 | |
| 2020/03 | 789 +0.6% | - | 1,658 +2.3% | |
| 2021/03 | 728 -7.7% | 33 | 1,662 +0.2% | |
| 2022/03 | 666 -8.5% | 29 -12.1% | 1,628 -2% | |
| 2023/03 | 648 -2.7% | 24 -17.2% | 1,618 -0.6% | |
| 2024/03 | 609 -6% | 24 ±0% | 1,650 +2% | |
| 2025/03 | 616 +1.1% | 26 +8.3% | 1,738 +5.3% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 資産 | 2013/03 | 405億 | - | 4811億 |
| 2014/03 | 409億 +1% | - | 4921億 +2.3% | |
| 2015/03 | 443億 +8.5% | - | 4818億 -2.1% | |
| 2016/03 | 478億 +7.8% | - | 5344億 +10.9% | |
| 2017/03 | 449億 -6.1% | - | 4806億 -10.1% | |
| 2018/03 | 472億 +5.3% | - | 5127億 +6.7% | |
| 2019/03 | 461億 -2.4% | - | 5105億 -0.4% | |
| 2020/03 | 510億 +10.8% | - | 5143億 +0.8% | |
| 2021/03 | 532億 +4.2% | 53.6億 | 5113億 -0.6% | |
| 2022/03 | 542億 +2% | 178億 +232.2% | 5352億 +4.7% | |
| 2023/03 | 558億 +3% | 181億 +1.8% | 5628億 +5.2% | |
| 2024/03 | 568億 +1.6% | 193億 +6.7% | 5983億 +6.3% | |
| 2025/03 | 587億 +3.4% | 194億 +0.6% | 5853億 -2.2% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 減損損失 | 2013/03 | 28百万 | - | 253百万 |
| 2014/03 | 177百万 +532.1% | - | 168百万 -33.6% | |
| 2015/03 | 33百万 -81.4% | - | 442百万 +163.1% | |
| 2016/03 | 66百万 +100% | - | 353百万 -20.1% | |
| 2017/03 | 481百万 +628.8% | - | 87百万 -75.4% | |
| 2018/03 | 162百万 -66.3% | - | 307百万 +252.9% | |
| 2019/03 | 9百万 -94.4% | - | 83百万 -73% | |
| 2020/03 | 187百万 +999.99% | - | 81百万 -2.4% | |
| 2021/03 | 59百万 -68.4% | - | 138百万 +70.4% | |
| 2022/03 | 140百万 +137.3% | - | 439百万 +218.1% | |
| 2023/03 | 136百万 -2.9% | - | 24百万 -94.5% | |
| 2024/03 | 214百万 +57.4% | - | 46百万 +91.7% | |
| 2025/03 | 46百万 -78.5% | - | 7百万 -84.8% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 持分法適用会社への投資額 | 2013/03 | - | - | 11.1億 |
| 2014/03 | - | - | 11.9億 +7.7% | |
| 2015/03 | - | - | 13.4億 +12.9% | |
| 2016/03 | - | - | 13.7億 +1.9% | |
| 2017/03 | - | - | 14.1億 +2.8% | |
| 2018/03 | - | - | 14.7億 +4.6% | |
| 2019/03 | - | - | 15.3億 +4% | |
| 2020/03 | - | - | 16.1億 +4.8% | |
| 2021/03 | - | - | 16.4億 +2.3% | |
| 2022/03 | - | 111億 | 16.4億 -0.1% | |
| 2023/03 | - | 111億 -0.2% | 17.4億 +6.3% | |
| 2024/03 | - | 111億 +0.5% | 18.4億 +5.6% | |
| 2025/03 | - | 108億 -2.6% | 18.9億 +2.8% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| のれん償却額 | 2013/03 | 20.8億 | - | 319百万 |
| 2014/03 | 20.9億 +0.1% | - | 302百万 -5.3% | |
| 2015/03 | 22.4億 +7.4% | - | 302百万 ±0% | |
| 2016/03 | 22.7億 +1.3% | - | 302百万 ±0% | |
| 2017/03 | 20.7億 -8.8% | - | 116百万 -61.6% | |
| 2018/03 | 18.3億 -11.7% | - | 127百万 +9.5% | |
| 2019/03 | 15.2億 -17.1% | - | 55百万 -56.7% | |
| 2020/03 | 5.57億 -63.3% | - | 83百万 +50.9% | |
| 2021/03 | 2.88億 -48.3% | - | 83百万 ±0% | |
| 2022/03 | 1.1億 -61.8% | - | 84百万 +1.2% | |
| 2023/03 | 1.09億 -0.9% | - | 55百万 -34.5% | |
| 2024/03 | 0.91億 -16.5% | - | 49百万 -10.9% | |
| 2025/03 | 0.67億 -26.4% | - | 49百万 ±0% | |
| 科目 | 年度 | 調剤薬局事業 | 医薬品製造販売事業 | 医薬品卸売事業 |
| 負ののれん償却額 | 2013/03 | 22百万 | - | 897百万 |
| 2014/03 | 26百万 +18.2% | - | 710百万 -20.8% | |
| 2015/03 | 26百万 ±0% | - | 335百万 -52.8% | |
| 2016/03 | 26百万 ±0% | - | - | |
| 2017/03 | 26百万 ±0% | - | - | |
| 2018/03 | 24百万 -7.7% | - | - | |
| 2019/03 | 17百万 -29.2% | - | - | |
| 2020/03 | 7百万 -58.8% | - | - | |
| 2021/03 | - | - | - | |
| 2022/03 | - | - | - | |
| 2023/03 | - | - | - | |
| 2024/03 | - | - | - | |
| 2025/03 | - | - | - |
セグメント四半期
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
|---|---|---|---|---|---|---|
| 調剤薬局事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 211億 | 211億 | 220億 | 214億 | 856億 |
| 2015/03 | 221億 +5% | 227億 +7.5% | 238億 +8.1% | 234億 +9.4% | 921億 +7.5% | |
| 2016/03 | 237億 +6.9% | 240億 +5.5% | 259億 +8.7% | 263億 +12.2% | 998億 +8.4% | |
| 2017/03 | 234億 -1.1% | 236億 -1.7% | 245億 -5.2% | 240億 -8.8% | 955億 -4.3% | |
| 2018/03 | 241億 +2.8% | 240億 +1.7% | 250億 +1.8% | 247億 +2.9% | 977億 +2.3% | |
| 2019/03 | 228億 -5.1% | 224億 -6.3% | 242億 -3.2% | 235億 -4.8% | 929億 -4.8% | |
| 2020/03 | 236億 +3.6% | 239億 +6.6% | 245億 +1.1% | 239億 +1.6% | 959億 +3.2% | |
| 2021/03 | 225億 -4.8% | 226億 -5.7% | 233億 -4.7% | 227億 -4.9% | 911億 -5% | |
| 2022/03 | 225億 +0.1% | 229億 +1.6% | 235億 +0.6% | 229億 +0.8% | 918億 +0.8% | |
| 2023/03 | 222億 -1.4% | 229億 -0.2% | 238億 +1.3% | 235億 +2.7% | 923億 +0.6% | |
| 2024/03 | 228億 +2.7% | 238億 +3.9% | 238億 ±0% | 234億 -0.3% | 938億 +1.6% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 3.25億 | 2.17億 | 4.9億 | 0.61億 | 10.9億 |
| 2015/03 | 0.18億 -94.5% | 0.54億 -75.1% | 3.86億 -21.2% | 11.4億 +999.99% | 16億 +45.9% | |
| 2016/03 | 4.46億 +999.99% | 4.85億 +798.1% | 9.77億 +153.1% | 10.2億 -10.6% | 29.2億 +83.3% | |
| 2017/03 | -1.18億 赤字 | 3.07億 -36.7% | 6.13億 -37.3% | 4.42億 -56.5% | 12.4億 -57.5% | |
| 2018/03 | 6.62億 | 6.43億 +109.4% | 11.7億 +90.4% | 10.9億 +147.1% | 35.6億 +186.5% | |
| 2019/03 | -0.53億 赤字 | 2.54億 -60.5% | 5.8億 -50.3% | 6.44億 -41% | 14.3億 -60% | |
| 2020/03 | 6.63億 | 6.95億 +173.6% | 4.24億 -26.9% | 9.18億 +42.5% | 27億 +89.5% | |
| 2021/03 | 1.18億 -82.2% | 6.45億 -7.2% | 9.79億 +130.9% | 9.46億 +3.1% | 26.9億 -0.4% | |
| 2022/03 | 3.5億 +196.6% | 9.67億 +49.9% | 9.63億 -1.6% | 6.83億 -27.8% | 29.6億 +10.2% | |
| 2023/03 | 1.33億 -62% | 7.45億 -23% | 8.6億 -10.7% | 6.93億 +1.5% | 24.3億 -18% | |
| 2024/03 | 1.12億 -15.8% | 7.83億 +5.1% | 5.51億 -35.9% | 1億 -85.6% | 15.5億 -36.4% | |
| 営業利益率 | 2014/03 | 1.5% | 1% | 2.2% | 0.3% | 1.3% |
| 2015/03 | 0.1% -1.4% | 0.2% -0.8% | 1.6% -0.6% | 4.9% +4.6% | 1.7% +0.4% | |
| 2016/03 | 1.9% +1.8% | 2% +1.8% | 3.8% +2.2% | 3.9% -1% | 2.9% +1.2% | |
| 2017/03 | -0.5% 赤字 | 1.3% -0.7% | 2.5% -1.3% | 1.8% -2.1% | 1.3% -1.6% | |
| 2018/03 | 2.8% | 2.7% +1.4% | 4.7% +2.2% | 4.4% +2.6% | 3.6% +2.3% | |
| 2019/03 | -0.2% 赤字 | 1.1% -1.6% | 2.4% -2.3% | 2.7% -1.7% | 1.5% -2.1% | |
| 2020/03 | 2.8% | 2.9% +1.8% | 1.7% -0.7% | 3.8% +1.1% | 2.8% +1.3% | |
| 2021/03 | 0.5% -2.3% | 2.9% ±0% | 4.2% +2.5% | 4.2% +0.4% | 3% +0.2% | |
| 2022/03 | 1.6% +1.1% | 4.2% +1.3% | 4.1% -0.1% | 3% -1.2% | 3.2% +0.2% | |
| 2023/03 | 0.6% -1% | 3.3% -0.9% | 3.6% -0.5% | 2.9% -0.1% | 2.6% -0.6% | |
| 2024/03 | 0.5% -0.1% | 3.3% ±0% | 2.3% -1.3% | 0.4% -2.5% | 1.6% -1% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 医薬品製造販売事業 | ||||||
| 売上高 1Q2Q 3Q | 2021/03 | 6.56億 | 4.48億 | 6.54億 | 4.92億 | 22.5億 |
| 2022/03 | 4.03億 -38.6% | 4.16億 -7.1% | 5.58億 -14.7% | 5.22億 +6.1% | 19億 -15.6% | |
| 2023/03 | 6.12億 +51.9% | 4.85億 +16.6% | 5.16億 -7.5% | 4.92億 -5.7% | 21.1億 +10.8% | |
| 2024/03 | 6.08億 -0.7% | 5.7億 +17.5% | 6.22億 +20.5% | 6.42億 +30.5% | 24.4億 +16% | |
| 営業利益 1Q2Q 3Q | 2021/03 | 341百万 | 88百万 | 207百万 | 93百万 | 729百万 |
| 2022/03 | 195百万 -42.8% | 117百万 +33% | 379百万 +83.1% | 193百万 +107.5% | 884百万 +21.3% | |
| 2023/03 | 288百万 +47.7% | 190百万 +62.4% | 237百万 -37.5% | 149百万 -22.8% | 864百万 -2.3% | |
| 2024/03 | 293百万 +1.7% | 143百万 -24.7% | 250百万 +5.5% | 69百万 -53.7% | 755百万 -12.6% | |
| 営業利益率 | 2021/03 | 52% | 19.6% | 31.7% | 18.9% | 32.4% |
| 2022/03 | 48.4% -3.6% | 28.1% +8.5% | 67.9% +36.2% | 37% +18.1% | 46.6% +14.2% | |
| 2023/03 | 47.1% -1.3% | 39.2% +11.1% | 45.9% -22% | 30.3% -6.7% | 41% -5.6% | |
| 2024/03 | 48.2% +1.1% | 25.1% -14.1% | 40.2% -5.7% | 10.7% -19.6% | 30.9% -10.1% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| 医薬品卸売事業 | ||||||
| 売上高 1Q2Q 3Q | 2014/03 | 0.27兆 | 0.27兆 | 0.3兆 | 0.27兆 | 1.1兆 |
| 2015/03 | 0.26兆 -3.3% | 0.26兆 -4.4% | 0.29兆 -1.6% | 0.26兆 -3.2% | 1.07兆 -3.1% | |
| 2016/03 | 0.27兆 +4.6% | 0.28兆 +10.2% | 0.34兆 +16.8% | 0.31兆 +19.7% | 1.21兆 +13% | |
| 2017/03 | 0.29兆 +7.2% | 0.28兆 -1.8% | 0.3兆 -12.7% | 0.27兆 -14.1% | 1.13兆 -6% | |
| 2018/03 | 0.27兆 -5.4% | 0.27兆 -1.9% | 0.3兆 +1.3% | 0.26兆 -1.1% | 1.11兆 -1.8% | |
| 2019/03 | 0.28兆 +1.2% | 0.27兆 -1% | 0.31兆 +2.3% | 0.27兆 +2.5% | 1.13兆 +1.3% | |
| 2020/03 | 0.29兆 +3.7% | 0.3兆 +10.3% | 0.31兆 +0.1% | 0.27兆 ±0% | 1.17兆 +3.4% | |
| 2021/03 | 0.28兆 -4.6% | 0.27兆 -7.9% | 0.3兆 -4% | 0.27兆 -0.4% | 1.12兆 -4.3% | |
| 2022/03 | 0.28兆 +3.5% | 0.29兆 +5% | 0.3兆 +2.5% | 0.29兆 +7.9% | 1.17兆 +4.7% | |
| 2023/03 | 0.3兆 +5.4% | 0.33兆 +15.6% | 0.35兆 +16.2% | 0.31兆 +5.2% | 1.29兆 +10.7% | |
| 2024/03 | 0.33兆 +8.8% | 0.36兆 +7.7% | 0.36兆 +1.6% | 0.33兆 +8.3% | 1.38兆 +6.4% | |
| 営業利益 1Q2Q 3Q | 2014/03 | 20.4億 | 25.4億 | 46.9億 | 22億 | 115億 |
| 2015/03 | 29.2億 +43.1% | -2.93億 赤字 | 49.5億 +5.5% | 6.98億 -68.2% | 82.7億 -27.8% | |
| 2016/03 | 22.5億 -23.1% | 30.2億 | 74.4億 +50.4% | 146億 +999.99% | 273億 +230.2% | |
| 2017/03 | 40.4億 +79.8% | 38.1億 +26.1% | 32.1億 -56.8% | 29.3億 -79.9% | 140億 -48.8% | |
| 2018/03 | 22.2億 -45.1% | 27.8億 -27.1% | 50億 +55.5% | 71.6億 +144.3% | 172億 +22.6% | |
| 2019/03 | 25.6億 +15.3% | 29.4億 +5.6% | 54.8億 +9.7% | 51.1億 -28.6% | 161億 -6.2% | |
| 2020/03 | 33.2億 +29.8% | 47.9億 +63.1% | 54.9億 +0.2% | 44.1億 -13.7% | 180億 +12% | |
| 2021/03 | 21.6億 -35.2% | -3.11億 赤字 | 14.7億 -73.2% | 6.52億 -85.2% | 39.7億 -78% | |
| 2022/03 | 5.54億 -74.3% | 5.76億 | 25.2億 +70.8% | 63.2億 +869.2% | 99.7億 +151.1% | |
| 2023/03 | 21.5億 +288.3% | 29.3億 +408.9% | 43.2億 +71.4% | 46億 -27.3% | 140億 +40.4% | |
| 2024/03 | 22.2億 +3.3% | 45.9億 +56.5% | 49.5億 +14.6% | 77億 +67.4% | 195億 +39% | |
| 営業利益率 | 2014/03 | 0.8% | 0.9% | 1.6% | 0.8% | 1% |
| 2015/03 | 1.1% +0.3% | -0.1% 赤字 | 1.7% +0.1% | 0.3% -0.5% | 0.8% -0.2% | |
| 2016/03 | 0.8% -0.3% | 1.1% | 2.2% +0.5% | 4.7% +4.4% | 2.3% +1.5% | |
| 2017/03 | 1.4% +0.6% | 1.4% +0.3% | 1.1% -1.1% | 1.1% -3.6% | 1.2% -1.1% | |
| 2018/03 | 0.8% -0.6% | 1% -0.4% | 1.7% +0.6% | 2.7% +1.6% | 1.5% +0.3% | |
| 2019/03 | 0.9% +0.1% | 1.1% +0.1% | 1.8% +0.1% | 1.9% -0.8% | 1.4% -0.1% | |
| 2020/03 | 1.2% +0.3% | 1.6% +0.5% | 1.8% ±0% | 1.6% -0.3% | 1.5% +0.1% | |
| 2021/03 | 0.8% -0.4% | -0.1% 赤字 | 0.5% -1.3% | 0.2% -1.4% | 0.4% -1.1% | |
| 2022/03 | 0.2% -0.6% | 0.2% | 0.8% +0.3% | 2.2% +2% | 0.9% +0.5% | |
| 2023/03 | 0.7% +0.5% | 0.9% +0.7% | 1.2% +0.4% | 1.5% -0.7% | 1.1% +0.2% | |
| 2024/03 | 0.7% ±0% | 1.3% +0.4% | 1.4% +0.2% | 2.3% +0.8% | 1.4% +0.3% | |
| 科目 | 年度 | 1Q | 2Q | 3Q | 4Q | 通期 |
| その他周辺事業 | ||||||
| 売上高 1Q2Q 3Q | 2021/03 | 1.98億 | 3.46億 | 2.6億 | - | - |
| 2022/03 | 9.66億 +387.9% | 10.4億 +200% | 11.2億 +330.8% | - | - | |
| 2023/03 | 11.5億 +19.3% | 13.8億 +32.5% | 12.5億 +11.6% | - | - | |
| 2024/03 | 11.3億 -1.6% | 11.7億 -15.2% | 11.1億 -11.6% | - | - | |
| 営業利益 1Q2Q 3Q | 2021/03 | -163百万 | -79百万 | -109百万 | - | - |
| 2022/03 | - | - | 208百万 | - | - | |
| 2023/03 | 94百万 | 152百万 | 203百万 -2.4% | - | - | |
| 2024/03 | 35百万 -62.8% | 104百万 -31.6% | 119百万 -41.4% | - | - | |
| 営業利益率 | 2021/03 | -82.3% | -22.8% | -41.9% | - | - |
| 2022/03 | - | - | 18.6% | - | - | |
| 2023/03 | 8.2% | 11.1% | 16.2% -2.4% | - | - | |
| 2024/03 | 3.1% -5.1% | 8.9% -2.2% | 10.8% -5.4% | - | - | |
10年以上蓄積したファイナンスデータとAIを掛け合わせて、投資の意思決定を加速させるポジションです。
